OSMT - Osmotica Pharmaceuticals EPS misses by $0.64 misses on revenue
Osmotica Pharmaceuticals (OSMT): Q4 GAAP EPS of -$0.88 misses by $0.64.Revenue of $34.53M (-42.4% Y/Y) misses by $1.2M.Strengthened balance sheet by reducing $50 million in debt and increasing cash.Press Release
For further details see:
Osmotica Pharmaceuticals EPS misses by $0.64, misses on revenue